SecurityHCOM / Hawaiian Telcom Holdco, Inc. (420031106)
IndustryCommunications Services, Not Elsewhere Classified
Common Shares Outstanding11,667,205 shares (as of 2018-03-31)
Total Insiders23
Total Directors15
Total Officers5

Stock Insider Trading (from SEC Form 4)

Hawaiian Telcom Holdco, Inc. insider trades are listed in the following table, followed by a table containing the full transaction history. Insiders are officers, directors, or significant investors in a company. In general, it is generally illegal for insiders to make trades in their companies based on specific, non-public information. This does not mean it is illegal for them to make any trades in their own companies. However, they must report all trades to the SEC via a Form 4.

HCOM / Hawaiian Telcom Holdco, Inc. insiders include Haruki Warren H, Twin Haven Special Opportunities Partners IV, LLC, BESSEY DAN T, Reich Robert F Paul Kevin T., Twin Haven Special Opportunities Fund IV, L.P., OLDHAM STEVEN C, Komeiji John T, YEAMAN ERIC K, Webster Robert, Deckoff Stephen H, and Twin Haven Special Opportunities Partners III, L.L.C., TWIN HAVEN SPECIAL OPPORTUNITIES FUND III, L.P., JALKUT RICHARD A, Mellinger Paul, Twin Haven Capital Partners, L.L.C., Barber Scott K, BLACK DIAMOND CAPITAL MANAGEMENT, L.L.C., DODS WALTER A JR, Cellar Kurt Matthew, Fontana Nathel John III, Phillips Bernard R III, CHING MEREDITH J, .

Insider Roster

Insider Dir Off 10% Shares Owned
BLACK DIAMOND CAPITAL MANAGEMENT, L.L.C. 10% Owner
Deckoff Stephen H 10% Owner
X 0
Twin Haven Special Opportunities Partners III, L.L.C. 10% Owner
Twin Haven Special Opportunities Partners IV, LLC 10% Owner
Webster Robert Director, 10% Owner
Mellinger Paul 10% Owner
Twin Haven Special Opportunities Fund IV, L.P. 10% Owner
TWIN HAVEN SPECIAL OPPORTUNITIES FUND III, L.P. 10% Owner
Twin Haven Capital Partners, L.L.C. 10% Owner
X 0
Fontana Nathel John III Director
X 0
DODS WALTER A JR Director
X 0
CHING MEREDITH J Director
X 0
Cellar Kurt Matthew Director
X 0
BESSEY DAN T SVP & Chief Financial Officer
X 0
Komeiji John T SVP & General Counsel
X 0
Paul Kevin T. SVP - Technology
X 0
Barber Scott K Chief Executive Officer, Director
X X 0
YEAMAN ERIC K Director
X 0
OLDHAM STEVEN C Director
X 0
JALKUT RICHARD A Director
X 0
Twin Haven Capital Partners, L.L.C. Director, 10% Owner
Webster Robert Director, 10% Owner
Twin Haven Special Opportunities Partners III, L.L.C. Director, 10% Owner
Twin Haven Special Opportunities Partners IV, LLC Director, 10% Owner
TWIN HAVEN SPECIAL OPPORTUNITIES FUND III, L.P. Director, 10% Owner
Twin Haven Special Opportunities Fund IV, L.P. Director, 10% Owner
Mellinger Paul Director, 10% Owner
X X 2,620,072
Twin Haven Special Opportunities Fund IV, L.P. Director, 10% Owner
Twin Haven Capital Partners, L.L.C. Director, 10% Owner
TWIN HAVEN SPECIAL OPPORTUNITIES FUND III, L.P. Director, 10% Owner
Twin Haven Special Opportunities Partners III, L.L.C. Director, 10% Owner
Twin Haven Special Opportunities Partners IV, LLC Director, 10% Owner
Mellinger Paul Director, 10% Owner
Webster Robert Director, 10% Owner
X X 2,616,442
Phillips Bernard R III Director
X
Haruki Warren H Director
X
Webster Robert Director, 10% Owner
Twin Haven Special Opportunities Fund IV, L.P. Director, 10% Owner
TWIN HAVEN SPECIAL OPPORTUNITIES FUND III, L.P. Director, 10% Owner
Mellinger Paul Director, 10% Owner
Twin Haven Capital Partners, L.L.C. Director, 10% Owner
Twin Haven Special Opportunities Partners IV, LLC Director, 10% Owner
Twin Haven Special Opportunities Partners III, L.L.C. Director, 10% Owner
X X
Mellinger Paul Director, 10% Owner
Webster Robert Director, 10% Owner
Twin Haven Special Opportunities Partners IV, LLC Director, 10% Owner
Twin Haven Capital Partners, L.L.C. Director, 10% Owner
Twin Haven Special Opportunities Fund IV, L.P. Director, 10% Owner
X X
Twin Haven Special Opportunities Partners IV, LLC Director, 10% Owner
Mellinger Paul Director, 10% Owner
Webster Robert Director, 10% Owner
Twin Haven Capital Partners, L.L.C. Director, 10% Owner
Twin Haven Special Opportunities Fund IV, L.P. Director, 10% Owner
X X
Reich Robert F SVP, CFO and Treasurer
X

Transaction History

Click the link icon to see the full transaction history. Transactions reported as part of a 10b-5 automatic trading plan will have an X in the column marked 10b-5.

Tran
Date
Form Insider Code 10b-5 Direct Share
Price
Shares
Changed
Remaining
Shares
Post Value
2018-07-02 4 BLACK DIAMOND CAPITAL MANAGEMENT, L.L.C. See Footnotes J I -2,651,068 0
2018-07-02 4 BLACK DIAMOND CAPITAL MANAGEMENT, L.L.C. J D -641 0
2018-07-02 4 Webster Robert See footnotes D I -1,457,000 0
2018-07-02 4 Webster Robert See footnotes D I -1,153,000 0
2018-07-02 4 Webster Robert D D -10,072 0
2018-07-02 4 JALKUT RICHARD A D D -28,675 0
2018-07-02 4 OLDHAM STEVEN C D D -21,553 0
2018-07-02 4 YEAMAN ERIC K D D -189,995 0
2018-07-02 4 Barber Scott K D D -77,064 0
2018-07-02 4 Barber Scott K F D -36,673 77,064
2018-07-02 4 Barber Scott K A D 45,168 113,737
2018-07-02 4 Paul Kevin T. D D -27,782 0
2018-07-02 4 Paul Kevin T. F D -6,109 27,782
2018-07-02 4 Paul Kevin T. A D 10,398 33,891
2018-07-02 4 Komeiji John T D D -67,990 0
2018-07-02 4 Komeiji John T F D -2,994 67,990
2018-07-02 4 Komeiji John T A D 5,376 70,984
2018-07-02 4 BESSEY DAN T D D -32,240 0
2018-07-02 4 BESSEY DAN T F D -12,658 32,240
2018-07-02 4 BESSEY DAN T A D 19,325 44,898
2018-07-02 4 Cellar Kurt Matthew D D -46,553 0
2018-07-02 4 CHING MEREDITH J D D -12,175 0
2018-07-02 4 DODS WALTER A JR D D -21,553 0
2018-07-02 4 Fontana Nathel John III D D -7,473 0
2018-04-30 4 Cellar Kurt Matthew A D 3,630 46,553
2018-04-30 4 CHING MEREDITH J A D 3,630 12,175
2018-04-30 4 DODS WALTER A JR A D 3,630 21,553
2018-04-30 4 Fontana Nathel John III A D 3,630 7,473
2018-04-30 4 JALKUT RICHARD A A D 4,900 28,675
2018-04-30 4 OLDHAM STEVEN C A D 3,630 21,553
2018-04-30 4 YEAMAN ERIC K A D 3,630 189,995
2017-04-30 4 Webster Robert A D 3,630 2,620,072
2018-03-12 4 Paul Kevin T. F D 27.95 -1,645 23,493
2018-03-12 4 Paul Kevin T. D D -274 25,138
2018-03-12 4 Paul Kevin T. A D 1,348 25,412
2018-03-08 4 Paul Kevin T. A D 3,289 24,064
2018-03-12 4 Barber Scott K F D 27.95 -5,455 68,569
2018-03-12 4 Barber Scott K D D -711 74,024
2018-03-12 4 Barber Scott K A D 4,614 74,735
2018-03-08 4 Barber Scott K A D 15,430 70,121
2018-03-12 4 BESSEY DAN T F D 27.95 -2,331 25,573
2018-03-12 4 BESSEY DAN T A D 2,389 27,904
2018-03-08 4 BESSEY DAN T A D 6,169 25,515
2018-03-12 4 Komeiji John T F D 27.95 -2,567 65,608
2018-03-12 4 Komeiji John T D D -393 68,175
2018-03-12 4 Komeiji John T A D 2,301 68,568
2018-03-08 4 Komeiji John T A D 4,988 66,267
2017-04-27 4 Webster Robert A D 3,843 2,616,442
2017-04-27 4 JALKUT RICHARD A A D 5,188 22,430
2017-04-27 4 YEAMAN ERIC K A D 3,843 186,365
P
Open market or private purchase of non-derivative or derivative security
S
Open market or private sale of non-derivative or derivative security
A
Grant, award, or other acquisition of securities from the company (such as an option)
C
Conversion of derivative
D
Sale or transfer of securities back to the company
F
Payment of exercise price or tax liability using portion of securities received from the company
G
Gift of securities by or to the insider
K
Equity swaps and similar hedging transactions
M
Exercise or conversion of derivative security received from the company (such as an option)
V
A transaction voluntarily reported on Form 4
J
Other (accompanied by a footnote describing the transaction)

Related Articles

KTOV: Kitov Pharamceuticals Holdings Analysis and Research Report

2018-07-17 - Asif

History and Development of the Company Kitov Pharma was incorporated under the laws of the State of Israel (under a previous name) on August 12, 1968 and its ordinary shares were originally listed for trading on the TASE in 1978. The company's ordinary shares are currently traded on the TASE under the symbol “KTOV”, and its ADSs and its public warrants are traded on NASDAQ under the symbols “KTOV” and “KTOVW”, respectively. In October 2012, the District Court in Lod, Israel approved the creditors arrangement in accordance with Section 350 of the Companies Law in order to effectuate the sale by Kitov Pharma (then known as Mainrom Line Logistics Ltd.) of all its activities, assets, rights, obligations and liabilities to a private company held by its then controlling shareholders, and all rights of Kitov Pharma’s creditors against it were extinguished. The sale was made pursuant to an arrangement between Kitov Pharma and its creditors. Following such sale and a related cash...

ATHX: Athersys Analysis and Research Report

2018-07-17 - Asif

Overview and Recent Developments Athersys is an international biotechnology company that is focused primarily in the field of regenerative medicine. The company's MultiStem® cell therapy, a patented and proprietary allogeneic stem cell product, is its lead platform product and is currently in later-stage clinical development. The company's current clinical development programs are focused on treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, certain pulmonary conditions and other conditions where the current standard of care is limited or inadequate for many patients, particularly in the critical care segment. Current Programs By applying its proprietary MultiStem cell therapy product, the company established therapeutic product development programs treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, and other conditions. The company's programs in the clinical development stage include ...

CYTX: Cytori Therapeutics Analysis and Research Report

2018-07-16 - Asif

General The company's objective is to build a profitable and growing specialty therapeutics company. To meet this objective, Cytori Therapeutics has acquired and are developing two technology platforms that hold promise for treating millions of patients and represent significant potential for increasing shareholder value. The company's current corporate activities fall substantially into advancing these platforms: Cytori Nanomedicine and Cytori Cell Therapy. The Cytori Nanomedicine platform features a versatile liposomal nanoparticle technology for drug encapsulation that has thus far provided the foundation to bring two promising drugs into mid/late stage clinical trials. Nanoparticle encapsulation is promising because it can help improve the delivery and metabolism of many drugs, thus potentially enhancing the therapeutic profile and patient benefits. The company's lead drug candidate, ATI-0918 is a generic version of pegylated liposomal encapsulated doxorubicin. Pegyl...

Related News Stories

Telecom Stock Roundup: Verizon Go90 Pullout, China Mobile's US Entry Block & More

2018-07-05 zacks
In the last five trading days, telecom stocks witnessed a sharp rise initially as China eased some foreign investment curbs but fell slightly thereafter to maintain a flat trajectory. The stocks regained the lost ground later in the week due to temporary relief to ZTE to resume some business activities. Amid the looming trade war tensions between the United States and China, the communist nation took a positive step toward easing the limits on foreign ownership in some of its closely guarded sectors. (6-0)

Cincinnati Bell Completes Acquisition of Hawaiian Telcom

2018-07-03 zacks
Cincinnati Bell Inc. (CBB - Free Report) recently announced that it has completed the acquisition of Hawaiian Telcom Holdco, Inc. . The financial terms of the deal remained undisclosed. Headquartered in Honolulu, Hawaiian Telcom is Hawai‘i’s fiber-centric technology leader and provides integrated communications, broadband, data center and entertainment solutions for business and residential customers. (2-0)

Stocks To Watch: Tariffs Don't Take Holidays

2018-06-30 seekingalpha
Welcome to Seeking Alpha's Stocks to Watch - a preview of key events scheduled for the next week. Follow this account and turn the e-mail alert on to receive this article in your inbox every Saturday morning. As usual, a new quarter and the second half of the trading year will begin with a shortened week due to the Independence Day holiday -- a "trading week interruptus," with July 4 landing on Wednesday. (254-5)

Telecom Stock Roundup: VZ Reality Ad Launch, CBB's Merger Deal & More

2018-06-21 zacks
In the last five trading days, telecom stocks flattered to deceive as the initial upturn was replaced by a persistent downturn for the most part of the past week as President Trump renewed fears of a fresh trade war with China. The on-again off-again trade war between the United States and China took a new turn when Trump imposed a fresh salvo of tariffs worth $50 billion on Chinese imports last week. (43-0)

Cincinnati Bell Wins FCC Approval to Acquire Hawaiian Telcom

2018-06-20 zacks
Cincinnati Bell Inc. (CBB - Free Report) recently announced that it has received final regulatory approval from the U.S. Federal Communications Commission (“FCC”) to acquire Hawaiian Telcom Holdco, Inc. . The transaction is now subject to the satisfaction of customary closing conditions. Headquartered in Honolulu, Hawaiian Telcom is Hawai‘i’s technology leader. The company provides integrated communications, broadband, data center and entertainment solutions for business and residential customers. (20-0)